Reacción #1869182

ord-36a25b36fc474b1286cb28173d92e0f6

Ecuación de reacción

NC(CO)(CO)CO
trisamine
O=C1c2ccccc2OC2(CCNCC2)CN1Cc1ccccc1
compound
O=C1c2ccccc2OC2(CCNCC2)CN1Cc1ccccc1
4-benzyl-3,4-dihydro-5H-spiro[1,4-benzoxazepine-2,4′-piperidin]-5-one
O=C(Cl)C1CCCC1
cyclopentanecarbonylchloride
O=C1c2ccccc2OC2(CCN(C(=O)C3CCCC3)CC2)CN1Cc1ccccc1
4-benzyl-1′-(cyclopentylcarbonyl)-3,4-dihydro-5H-spiro[1,4-benzoxazepine-2,4′-piperidin]-5-one

Disolventes

Condiciones de reacción

Temperatura
25°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGthe mixture was stirred overnight at 25° C
  2. 2
    FiltraciónThe mixture was filtered
  3. 3
    Concentraciónthe filtrate was concentrated
  4. 4
    Otroto give the compound of the present invention

Procedimiento

To a solution of the compound prepared in Example 30 (0.010 mmol) in dichloroethane (0.7 mL) were added cyclopentanecarbonylchloride (0.020 mmol) and poly(4-vinylpyridine) (2% cross-linked, Aldrich, CAS#9017-40-7) (5.3 mg). The mixture was stirred overnight at 25° C. To the reaction mixture was added PS-trisamine (Argonaut, product number 800229, loading; 4.36 mmol/g) (6.9 mg), and the mixture was stirred overnight at 25° C. The mixture was filtered and the filtrate was concentrated to give the compound of the present invention having the following physical data.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07498323B2uspto-grants-2009_03